Urgent.News

What's breaking now, across thousands of outlets.

World

Musk still a friend despite backing away from MAGA, Trump says

Washington — US President Donald Trump has said he still considers Elon Musk a friend, despite the tech billionaire attempting to distance himself from Trump's Make America Great Again (MAGA) movement. Tesla and SpaceX chief executive Musk told The New York Times on Wednesday that he was "not MAGA." Speaking to NBC News on Thursday, Trump said Elon was "a friend of mine." "MAGA, to me, means…

Musk still a friend despite backing away from MAGA, Trump says

US President Donald Trump has maintained that Elon Musk remains a friend, according to the tech billionaire's recent interview with The New York Times. Musk denied backing away from Trump's Make America Great Again (MAGA) movement, stating he was "not MAGA" to The New York Times on Wednesday. However, Trump considers Musk to be a friend and expressed disappointment over the billionaire's decision to donate nearly $500 million to Republican candidates in the recent midterm elections.

Trump suggested Musk's intentions were good, but he did not agree with the billionaire's commitment to a specific set of policies. Trump noted that Musk had traveled with him during his presidency, adding that Musk had been with him "the whole time."

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 3 other outlets

Every outlet that reported this, and when →

Read the original at koreatimes.co.kr →

More in World

German Court Overturns Keytruda SC Sales Ban, Opening Door to European Expansion

The path to market entry in Germany, Europe’s largest pharmaceutical market, has opened for Keytruda SC, the subcutaneous formulation of the immuno-oncology drug developed by U.S.-based Merck (MSD)…

  • German court overturns ban on Keytruda SC sales, allowing European expansion.
  • Merck wins patent disputes in Germany and U.S., clearing path for drug's entry.
  • Keytruda SC's subcutaneous formulation reduces treatment time to one to two minutes.

More from Friday 20 November →